TCBP early but an alpha alreadyLooking good at 2.48 after a pullback intraday. It was a gap up but pulled back. Tight stop is needed, just incase
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.34 M USD
0.00 USD
About TC BioPharm (Holdings) plc
Sector
Industry
CEO
Bryan Kobel
Website
Headquarters
Motherwell
Founded
2021
FIGI
BBG0136BRF62
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.